Synonyms: CVM-1118 | TRX 818 | TRX-818
Compound class:
Synthetic organic
Comment: Foslinanib (CVM-1118) is an orally bioavailable protein kinase inhibitor with antiangiogenic and antineoplastic activities [1].
|
|
Classification | |
Compound class | Synthetic organic |
IUPAC Name |
[2-(3-fluorophenyl)-6-methoxy-4-oxo-1H-quinolin-5-yl] dihydrogen phosphate |
International Nonproprietary Names | |
INN number | INN |
10721 | foslinanib |
Synonyms |
CVM-1118 | TRX 818 | TRX-818 |
Database Links | |
CAS Registry No. | 1256037-60-1 (source: WHO INN record) |
GtoPdb PubChem SID | 442878655 |
PubChem CID | 49840582 |
Search Google for chemical match using the InChIKey | ZDWFMAHQGDEALT-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | ZDWFMAHQGDEALT |
Search PubMed clinical trials | foslinanib |
Search PubMed titles | foslinanib |
Search PubMed titles/abstracts | foslinanib |
UniChem Compound Search for chemical match using the InChIKey | ZDWFMAHQGDEALT-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | ZDWFMAHQGDEALT-UHFFFAOYSA-N |